Cervus elaphus chromosome 26, mCerEla1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Cervidae; Cervinae; Cervus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU343103.1.\nAssembly name: mCerEla1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/07/07. The original whole-genome shotgun project has the\naccession CAJVBL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Cervus elaphus Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC122684278
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cyclin-Y-like protein 1, transcript variant X3
cyclin-Y-like protein 1, transcript variant X2
cyclin-Y-like protein 1, transcript variant X4
cyclin-Y-like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor 5D14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
non-histone chromosomal protein HMG-17-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
T-box transcription factor 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
T-box transcription factor 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 8 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
T-box transcription factor TBX18 isoform X1
T-box transcription factor 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
T-box transcription factor TBX18 isoform X3
T-box transcription factor TBX18 isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
centrosomal protein 162, transcript variant X4
centrosomal protein 162, transcript variant X3
centrosomal protein 162, transcript variant X1
centrosomal protein 162, transcript variant X2
centrosomal protein of 162 kDa isoform X1
centrosomal protein of 162 kDa isoform X3
centrosomal protein of 162 kDa isoform X2
melanocortin 2 receptor accessory protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
melanocortin 2 receptor accessory protein 2, transcript variant X2
melanocortin 2 receptor accessory protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
melanocortin 2 receptor accessory protein 2, transcript variant X3
melanocortin 2 receptor accessory protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
melanocortin 2 receptor accessory protein 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
melanocortin 2 receptor accessory protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
melanocortin 2 receptor accessory protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
melanocortin 2 receptor accessory protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
melanocortin-2 receptor accessory protein 2 isoform X3
melanocortin-2 receptor accessory protein 2 isoform X1
melanocortin-2 receptor accessory protein 2 isoform X2
melanocortin-2 receptor accessory protein 2 isoform X4
melanocortin-2 receptor accessory protein 2 isoform X5
cytochrome b5 reductase 4, transcript variant X2
cytochrome b5 reductase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
thymocyte selection associated, transcript variant X2
thymocyte selection associated, transcript variant X1
protein tyrosine phosphatase receptor type K, transcript variant X3
protein tyrosine phosphatase receptor type K, transcript variant X4
protein tyrosine phosphatase receptor type K, transcript variant X2
protein tyrosine phosphatase receptor type K, transcript variant X1
receptor-type tyrosine-protein phosphatase kappa isoform X4
receptor-type tyrosine-protein phosphatase kappa isoform X2
receptor-type tyrosine-protein phosphatase kappa isoform X3
receptor-type tyrosine-protein phosphatase kappa isoform X1
protein tyrosine phosphatase receptor type K, transcript variant X5
receptor-type tyrosine-protein phosphatase kappa isoform X5
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transfer RNA tyrosine (anticodon AUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
laminin subunit alpha 2, transcript variant X6
laminin subunit alpha 2, transcript variant X7
laminin subunit alpha 2, transcript variant X3
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
laminin subunit alpha 2, transcript variant X1
laminin subunit alpha 2, transcript variant X2
laminin subunit alpha 2, transcript variant X4
laminin subunit alpha 2, transcript variant X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Rho GTPase activating protein 18, transcript variant X2
Rho GTPase activating protein 18, transcript variant X1
Rho GTPase activating protein 18, transcript variant X3
Rho GTPase activating protein 18, transcript variant X4
rho GTPase-activating protein 18 isoform X2
rho GTPase-activating protein 18 isoform X1
rho GTPase-activating protein 18 isoform X3
rho GTPase-activating protein 18 isoform X4
transmembrane protein 244, transcript variant X3
transmembrane protein 244, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transmembrane protein 244, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 244, transcript variant X4
L3MBTL histone methyl-lysine binding protein 3, transcript variant X2
L3MBTL histone methyl-lysine binding protein 3, transcript variant X4
L3MBTL histone methyl-lysine binding protein 3, transcript variant X6
L3MBTL histone methyl-lysine binding protein 3, transcript variant X5
L3MBTL histone methyl-lysine binding protein 3, transcript variant X7
L3MBTL histone methyl-lysine binding protein 3, transcript variant X1
L3MBTL histone methyl-lysine binding protein 3, transcript variant X9
L3MBTL histone methyl-lysine binding protein 3, transcript variant X3
L3MBTL histone methyl-lysine binding protein 3, transcript variant X8
lethal(3)malignant brain tumor-like protein 3 isoform X1
lethal(3)malignant brain tumor-like protein 3 isoform X2
lethal(3)malignant brain tumor-like protein 3 isoform X3
lethal(3)malignant brain tumor-like protein 3 isoform X4
sterile alpha motif domain containing 3, transcript variant X2
sterile alpha motif domain containing 3, transcript variant X1
sterile alpha motif domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 48% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 200A, transcript variant X3
transmembrane protein 200A, transcript variant X2
transmembrane protein 200A, transcript variant X1
transmembrane protein 200A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 200A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 200A, transcript variant X6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 49% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: small leucine-rich protein 1
erythrocyte membrane protein band 4.1 like 2, transcript variant X13
erythrocyte membrane protein band 4.1 like 2, transcript variant X12
erythrocyte membrane protein band 4.1 like 2, transcript variant X10
erythrocyte membrane protein band 4.1 like 2, transcript variant X7
erythrocyte membrane protein band 4.1 like 2, transcript variant X11
erythrocyte membrane protein band 4.1 like 2, transcript variant X9
erythrocyte membrane protein band 4.1 like 2, transcript variant X8
erythrocyte membrane protein band 4.1 like 2, transcript variant X1
erythrocyte membrane protein band 4.1 like 2, transcript variant X2
erythrocyte membrane protein band 4.1 like 2, transcript variant X5
erythrocyte membrane protein band 4.1 like 2, transcript variant X4
erythrocyte membrane protein band 4.1 like 2, transcript variant X3
erythrocyte membrane protein band 4.1 like 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00561
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
A-kinase anchoring protein 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
A-kinase anchoring protein 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
A-kinase anchoring protein 7, transcript variant X1
A-kinase anchoring protein 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
A-kinase anchoring protein 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
A-kinase anchoring protein 7, transcript variant X5
mediator complex subunit 23, transcript variant X3
mediator complex subunit 23, transcript variant X2
mediator complex subunit 23, transcript variant X1
mediator of RNA polymerase II transcription subunit 23 isoform X3
mediator of RNA polymerase II transcription subunit 23 isoform X2
mediator of RNA polymerase II transcription subunit 23 isoform X1
ectonucleotide pyrophosphatase/phosphodiesterase 3
ectonucleotide pyrophosphatase/phosphodiesterase family member 3
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1-like
ectonucleotide pyrophosphatase/phosphodiesterase 1
ectonucleotide pyrophosphatase/phosphodiesterase family member 1
monooxygenase DBH like 1, transcript variant X3
monooxygenase DBH like 1, transcript variant X2
monooxygenase DBH like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 8 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 38 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 38 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 38 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 6 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
vascular non-inflammatory molecule 2-like, transcript variant X1
vascular non-inflammatory molecule 2-like, transcript variant X3
vascular non-inflammatory molecule 2-like isoform X1
vascular non-inflammatory molecule 2-like isoform X3
vascular non-inflammatory molecule 2-like, transcript variant X2
vascular non-inflammatory molecule 2-like isoform X2
solute carrier family 18 member B1, transcript variant X1
solute carrier family 18 member B1, transcript variant X2
solute carrier family 18 member B1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00186
COORDINATES: nucleotide motif:Rfam:12.0:RF00609
COORDINATES: nucleotide motif:Rfam:12.0:RF00438
EYA transcriptional coactivator and phosphatase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EYA transcriptional coactivator and phosphatase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EYA transcriptional coactivator and phosphatase 4, transcript variant X4
EYA transcriptional coactivator and phosphatase 4, transcript variant X6
EYA transcriptional coactivator and phosphatase 4, transcript variant X10
EYA transcriptional coactivator and phosphatase 4, transcript variant X11
EYA transcriptional coactivator and phosphatase 4, transcript variant X3
EYA transcriptional coactivator and phosphatase 4, transcript variant X5
EYA transcriptional coactivator and phosphatase 4, transcript variant X7
EYA transcriptional coactivator and phosphatase 4, transcript variant X9
EYA transcriptional coactivator and phosphatase 4, transcript variant X8
EYA transcriptional coactivator and phosphatase 4, transcript variant X12
solute carrier family 2 member 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 12 isoform X2
solute carrier family 2 member 12, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 12 isoform X1
solute carrier family 2 member 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 12 isoform X3
serum/glucocorticoid regulated kinase 1, transcript variant X1
serum/glucocorticoid regulated kinase 1, transcript variant X4
serum/glucocorticoid regulated kinase 1, transcript variant X2
serum/glucocorticoid regulated kinase 1, transcript variant X3
serine/threonine-protein kinase Sgk1 isoform X1
serine/threonine-protein kinase Sgk1 isoform X4
serine/threonine-protein kinase Sgk1 isoform X2
serine/threonine-protein kinase Sgk1 isoform X3
uncharacterized LOC122684321, transcript variant X1
uncharacterized LOC122684321, transcript variant X2
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
heterogeneous nuclear ribonucleoprotein A3-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein A3-like, transcript variant X1
heterogeneous nuclear ribonucleoprotein A3-like isoform X2
heterogeneous nuclear ribonucleoprotein A3-like isoform X1
aldehyde dehydrogenase 8 family member A1, transcript variant X1
aldehyde dehydrogenase 8 family member A1, transcript variant X2
2-aminomuconic semialdehyde dehydrogenase isoform X2
2-aminomuconic semialdehyde dehydrogenase isoform X1
aldehyde dehydrogenase 8 family member A1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aldehyde dehydrogenase 8 family member A1, transcript variant X4
2-aminomuconic semialdehyde dehydrogenase isoform X4
2-aminomuconic semialdehyde dehydrogenase isoform X3
HBS1 like translational GTPase, transcript variant X1
HBS1 like translational GTPase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
MYB proto-oncogene, transcription factor, transcript variant X4
MYB proto-oncogene, transcription factor, transcript variant X1
MYB proto-oncogene, transcription factor, transcript variant X3
transcriptional activator Myb isoform X4
transcriptional activator Myb isoform X1
transcriptional activator Myb isoform X3
MYB proto-oncogene, transcription factor, transcript variant X2
transcriptional activator Myb isoform X2
Abelson helper integration site 1, transcript variant X2
Abelson helper integration site 1, transcript variant X5
Abelson helper integration site 1, transcript variant X3
Abelson helper integration site 1, transcript variant X4
Abelson helper integration site 1, transcript variant X1
Abelson helper integration site 1, transcript variant X6
Abelson helper integration site 1, transcript variant X7
Abelson helper integration site 1, transcript variant X8
COORDINATES: nucleotide motif:Rfam:12.0:RF00045
uncharacterized LOC122684386, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122684386, transcript variant X1
uncharacterized LOC122684386, transcript variant X3
phosphodiesterase 7B, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase 7B isoform X2
phosphodiesterase 7B, transcript variant X5
phosphodiesterase 7B, transcript variant X4
phosphodiesterase 7B, transcript variant X3
cAMP-specific 3',5'-cyclic phosphodiesterase 7B isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase 7B isoform X4
phosphodiesterase 7B, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase 7B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial fission regulator 2, transcript variant X3
mitochondrial fission regulator 2, transcript variant X1
mitochondrial fission regulator 2, transcript variant X2
mitochondrial fission regulator 2, transcript variant X4
BCL2 associated transcription factor 1, transcript variant X9
BCL2 associated transcription factor 1, transcript variant X4
BCL2 associated transcription factor 1, transcript variant X8
BCL2 associated transcription factor 1, transcript variant X3
BCL2 associated transcription factor 1, transcript variant X7
BCL2 associated transcription factor 1, transcript variant X2
BCL2 associated transcription factor 1, transcript variant X6
BCL2 associated transcription factor 1, transcript variant X1
bcl-2-associated transcription factor 1 isoform X9
bcl-2-associated transcription factor 1 isoform X7
bcl-2-associated transcription factor 1 isoform X4
bcl-2-associated transcription factor 1 isoform X2
bcl-2-associated transcription factor 1 isoform X8
bcl-2-associated transcription factor 1 isoform X6
bcl-2-associated transcription factor 1 isoform X3
bcl-2-associated transcription factor 1 isoform X1
BCL2 associated transcription factor 1, transcript variant X5
bcl-2-associated transcription factor 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microtubule associated protein 7, transcript variant X3
microtubule associated protein 7, transcript variant X6
microtubule associated protein 7, transcript variant X4
microtubule associated protein 7, transcript variant X2
microtubule associated protein 7, transcript variant X1
microtubule associated protein 7, transcript variant X5
microtubule associated protein 7, transcript variant X7
mitogen-activated protein kinase kinase kinase 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
interleukin 20 receptor subunit alpha, transcript variant X2
interleukin 20 receptor subunit alpha, transcript variant X1
interleukin 20 receptor subunit alpha, transcript variant X3
interleukin 20 receptor subunit alpha, transcript variant X4
interleukin 20 receptor subunit alpha, transcript variant X5
interleukin-20 receptor subunit alpha isoform X2
interleukin-20 receptor subunit alpha isoform X1
interleukin-20 receptor subunit alpha isoform X3
interleukin-20 receptor subunit alpha isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
interferon gamma receptor 1, transcript variant X1
interferon gamma receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
tumor necrosis factor alpha-induced protein 3
p53 apoptosis effector related to PMP-22
ARFGEF family member 3, transcript variant X1
ARFGEF family member 3, transcript variant X2
ARFGEF family member 3, transcript variant X3
ARFGEF family member 3, transcript variant X4
ARFGEF family member 3, transcript variant X5
brefeldin A-inhibited guanine nucleotide-exchange protein 3 isoform X1
brefeldin A-inhibited guanine nucleotide-exchange protein 3 isoform X2
brefeldin A-inhibited guanine nucleotide-exchange protein 3 isoform X3
brefeldin A-inhibited guanine nucleotide-exchange protein 3 isoform X4
brefeldin A-inhibited guanine nucleotide-exchange protein 3 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
intraflagellar transport protein 25 homolog
transfer RNA serine (anticodon GGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
coiled-coil domain-containing protein 28A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
epithelial cell-transforming sequence 2 oncogene-like
RALBP1 associated Eps domain containing 1, transcript variant X2
RALBP1 associated Eps domain containing 1, transcript variant X1
RALBP1 associated Eps domain containing 1, transcript variant X3
RALBP1 associated Eps domain containing 1, transcript variant X5
RALBP1 associated Eps domain containing 1, transcript variant X4
ralBP1-associated Eps domain-containing protein 1 isoform X3
ralBP1-associated Eps domain-containing protein 1 isoform X5
ralBP1-associated Eps domain-containing protein 1 isoform X4
ralBP1-associated Eps domain-containing protein 1 isoform X2
ralBP1-associated Eps domain-containing protein 1 isoform X1
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122684439, transcript variant X1
uncharacterized LOC122684439, transcript variant X2
uncharacterized LOC122684439, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00280
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins
vesicle trafficking 1, transcript variant X1
vesicle trafficking 1, transcript variant X3
vesicle trafficking 1, transcript variant X2
vesicle trafficking 1, transcript variant X4
vacuolar protein sorting-associated protein VTA1 homolog isoform X1
vacuolar protein sorting-associated protein VTA1 homolog isoform X2
vacuolar protein sorting-associated protein VTA1 homolog isoform X3
vacuolar protein sorting-associated protein VTA1 homolog isoform X4
adhesion G protein-coupled receptor G6, transcript variant X1
adhesion G protein-coupled receptor G6, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
adhesion G protein-coupled receptor G6, transcript variant X7
adhesion G protein-coupled receptor G6, transcript variant X2
adhesion G protein-coupled receptor G6, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
adhesion G-protein coupled receptor G6 isoform X1
adhesion G-protein coupled receptor G6 isoform X5
adhesion G-protein coupled receptor G6 isoform X2
adhesion G-protein coupled receptor G6 isoform X6
adhesion G-protein coupled receptor G6 isoform X7
adhesion G protein-coupled receptor G6, transcript variant X3
adhesion G protein-coupled receptor G6, transcript variant X5
adhesion G protein-coupled receptor G6, transcript variant X6
adhesion G protein-coupled receptor G6, transcript variant X4
adhesion G-protein coupled receptor G6 isoform X3
adhesion G-protein coupled receptor G6 isoform X4
HIVEP zinc finger 2, transcript variant X4
HIVEP zinc finger 2, transcript variant X1
HIVEP zinc finger 2, transcript variant X2
HIVEP zinc finger 2, transcript variant X5
HIVEP zinc finger 2, transcript variant X3
androgen induced 1, transcript variant X3
androgen induced 1, transcript variant X2
androgen induced 1, transcript variant X1
androgen-induced gene 1 protein isoform X1
androgen-induced gene 1 protein isoform X2
androgen-induced gene 1 protein isoform X3
uncharacterized LOC122684380, transcript variant X2
uncharacterized LOC122684380, transcript variant X1
adenosine deaminase tRNA specific 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adenosine deaminase tRNA specific 2, transcript variant X1
tRNA-specific adenosine deaminase 2 isoform X1
tRNA-specific adenosine deaminase 2 isoform X2
adenosine deaminase tRNA specific 2, transcript variant X3
tRNA-specific adenosine deaminase 2 isoform X3
phosphatase and actin regulator 2, transcript variant X4
phosphatase and actin regulator 2, transcript variant X1
phosphatase and actin regulator 2, transcript variant X3
phosphatase and actin regulator 2 isoform X1
phosphatase and actin regulator 2 isoform X3
phosphatase and actin regulator 2 isoform X4
phosphatase and actin regulator 2, transcript variant X5
phosphatase and actin regulator 2 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
phosphatase and actin regulator 2, transcript variant X2
phosphatase and actin regulator 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger C2HC domain-containing protein 1B
PLAG1 like zinc finger 1, transcript variant X2
PLAG1 like zinc finger 1, transcript variant X14
PLAG1 like zinc finger 1, transcript variant X7
PLAG1 like zinc finger 1, transcript variant X12
PLAG1 like zinc finger 1, transcript variant X5
PLAG1 like zinc finger 1, transcript variant X16
PLAG1 like zinc finger 1, transcript variant X15
PLAG1 like zinc finger 1, transcript variant X13
PLAG1 like zinc finger 1, transcript variant X11
PLAG1 like zinc finger 1, transcript variant X4
PLAG1 like zinc finger 1, transcript variant X10
PLAG1 like zinc finger 1, transcript variant X6
PLAG1 like zinc finger 1, transcript variant X3
PLAG1 like zinc finger 1, transcript variant X1
PLAG1 like zinc finger 1, transcript variant X8
PLAG1 like zinc finger 1, transcript variant X9
PLAG1 like zinc finger 1, transcript variant X17
splicing factor 3b subunit 5, transcript variant X1
splicing factor 3b subunit 5, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 21% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
SNF2 histone linker PHD RING helicase, transcript variant X1
SNF2 histone linker PHD RING helicase, transcript variant X2
SNF2 histone linker PHD RING helicase, transcript variant X4
SNF2 histone linker PHD RING helicase, transcript variant X3
E3 ubiquitin-protein ligase SHPRH isoform X1
E3 ubiquitin-protein ligase SHPRH isoform X2
E3 ubiquitin-protein ligase SHPRH isoform X3
glutamate metabotropic receptor 1, transcript variant X1
glutamate metabotropic receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
metabotropic glutamate receptor 1 isoform X1
metabotropic glutamate receptor 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 4% coverage of the annotated genomic feature by RNAseq alignments
syntaxin binding protein 5, transcript variant X1
syntaxin binding protein 5, transcript variant X2
syntaxin binding protein 5, transcript variant X3
syntaxin binding protein 5, transcript variant X4
sterile alpha motif domain-containing protein 5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sterile alpha motif domain-containing protein 5, transcript variant X1
SAM and SH3 domain-containing protein 1 isoform X1
sterile alpha motif domain-containing protein 5 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
sterile alpha motif domain-containing protein 5, transcript variant X3
SAM and SH3 domain-containing protein 1 isoform X3
sterile alpha motif domain-containing protein 5, transcript variant X2
SAM and SH3 domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
sterile alpha motif domain-containing protein 5, transcript variant X4
SAM and SH3 domain-containing protein 1 isoform X4
sterile alpha motif domain-containing protein 5, transcript variant X5
SAM and SH3 domain-containing protein 1 isoform X5
sterile alpha motif domain-containing protein 5, transcript variant X6
SAM and SH3 domain-containing protein 1 isoform X6
40S ribosomal protein S6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
40S ribosomal protein S6-like isoform X2
40S ribosomal protein S6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
40S ribosomal protein S6-like isoform X1
uncharacterized LOC122684362, transcript variant X1
uncharacterized LOC122684362, transcript variant X2
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nuclear ubiquitous casein and cyclin-dependent kinase substrate 1-like
TGF-beta activated kinase 1 (MAP3K7) binding protein 2, transcript variant X1
TGF-beta activated kinase 1 (MAP3K7) binding protein 2, transcript variant X2
TGF-beta activated kinase 1 (MAP3K7) binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 isoform X1
TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 isoform X2
zinc finger CCCH-type containing 12D, transcript variant X1
zinc finger CCCH-type containing 12D, transcript variant X3
zinc finger CCCH-type containing 12D, transcript variant X2
zinc finger CCCH-type containing 12D, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, and 97% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase-like 4
glycoprotein integral membrane 1, transcript variant X2
glycoprotein integral membrane 1, transcript variant X1
glycoprotein integral membrane protein 1 isoform X1
glycoprotein integral membrane protein 1 isoform X2
katanin p60 ATPase-containing subunit A1
large tumor suppressor kinase 1, transcript variant X1
serine/threonine-protein kinase LATS1 isoform X1
large tumor suppressor kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
serine/threonine-protein kinase LATS1 isoform X2
large tumor suppressor kinase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
thioredoxin-related transmembrane protein 1-like
protein-L-isoaspartate (D-aspartate) O-methyltransferase, transcript variant X2
protein-L-isoaspartate (D-aspartate) O-methyltransferase, transcript variant X1
protein-L-isoaspartate(D-aspartate) O-methyltransferase isoform X1
protein-L-isoaspartate(D-aspartate) O-methyltransferase isoform X2
low-density lipoprotein receptor-related protein 11
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
UL16-binding protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UL16-binding protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 11-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 49% coverage of the annotated genomic feature by RNAseq alignments
retinoic acid early transcript 1E-like, transcript variant X2
retinoic acid early transcript 1E-like, transcript variant X1
retinoic acid early transcript 1E-like, transcript variant X4
retinoic acid early transcript 1E-like, transcript variant X6
retinoic acid early transcript 1E-like, transcript variant X3
retinoic acid early transcript 1E-like, transcript variant X5
retinoic acid early transcript 1E-like isoform X2
retinoic acid early transcript 1E-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments
UL16-binding protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
UL16-binding protein 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
low-density lipoprotein receptor-related protein 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 ESTs, 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
low-density lipoprotein receptor-related protein 11-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 11-like isoform X1
low-density lipoprotein receptor-related protein 11-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
UL16-binding protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 11-like isoform X3
uncharacterized LOC122684490, transcript variant X4
uncharacterized LOC122684490, transcript variant X3
uncharacterized LOC122684490, transcript variant X2
uncharacterized LOC122684490, transcript variant X1
uncharacterized LOC122684490, transcript variant X5
UL16-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
UL16-binding protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory inhibitor subunit 14C
protein phosphatase 1 regulatory subunit 14C
iodotyrosine deiodinase, transcript variant X3
iodotyrosine deiodinase, transcript variant X2
iodotyrosine deiodinase, transcript variant X1
pleckstrin homology and RhoGEF domain containing G1, transcript variant X4
pleckstrin homology and RhoGEF domain containing G1, transcript variant X1
pleckstrin homology domain-containing family G member 1 isoform X1
pleckstrin homology and RhoGEF domain containing G1, transcript variant X3
pleckstrin homology and RhoGEF domain containing G1, transcript variant X5
pleckstrin homology and RhoGEF domain containing G1, transcript variant X2
pleckstrin homology domain-containing family G member 1 isoform X2
pleckstrin homology domain-containing family G member 1 isoform X3
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like, transcript variant X1
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
monofunctional C1-tetrahydrofolate synthase, mitochondrial isoform X1
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like, transcript variant X4
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like, transcript variant X2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like, transcript variant X3
monofunctional C1-tetrahydrofolate synthase, mitochondrial isoform X2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like, transcript variant X6
monofunctional C1-tetrahydrofolate synthase, mitochondrial isoform X3
A-kinase anchoring protein 12, transcript variant X1
A-kinase anchoring protein 12, transcript variant X2
zinc finger and BTB domain containing 2, transcript variant X1
zinc finger and BTB domain containing 2, transcript variant X2
zinc finger and BTB domain-containing protein 2
required for meiotic nuclear division 1 homolog, transcript variant X5
required for meiotic nuclear division 1 homolog, transcript variant X1
required for meiotic nuclear division 1 homolog, transcript variant X2
required for meiotic nuclear division protein 1 homolog isoform X1
required for meiotic nuclear division protein 1 homolog isoform X2
required for meiotic nuclear division protein 1 homolog isoform X3
required for meiotic nuclear division 1 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
required for meiotic nuclear division 1 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
acidic residue methyltransferase 1, transcript variant X1
damage-control phosphatase ARMT1 isoform X1
acidic residue methyltransferase 1, transcript variant X2
damage-control phosphatase ARMT1 isoform X2
coiled-coil domain containing 170, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain containing 170, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain-containing protein 170 isoform X1
coiled-coil domain-containing protein 170 isoform X3
coiled-coil domain containing 170, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain containing 170, transcript variant X6
coiled-coil domain containing 170, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain containing 170, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain-containing protein 170 isoform X2
coiled-coil domain-containing protein 170 isoform X4
estrogen receptor 1, transcript variant X1
estrogen receptor 1, transcript variant X3
estrogen receptor 1, transcript variant X2
estrogen receptor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
spectrin repeat containing nuclear envelope protein 1, transcript variant X2
spectrin repeat containing nuclear envelope protein 1, transcript variant X3
spectrin repeat containing nuclear envelope protein 1, transcript variant X1
spectrin repeat containing nuclear envelope protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
vasoactive intestinal peptide, transcript variant X1
vasoactive intestinal peptide, transcript variant X2
vasoactive intestinal peptide, transcript variant X3
mitochondrial translation release factor 1 like, transcript variant X1
mitochondrial translation release factor 1 like, transcript variant X2
mitochondrial translation release factor 1 like, transcript variant X3
mitochondrial translation release factor 1 like, transcript variant X5
mitochondrial translation release factor 1 like, transcript variant X4
peptide chain release factor 1-like, mitochondrial isoform X1
peptide chain release factor 1-like, mitochondrial isoform X2
regulator of G protein signaling 17, transcript variant X2
regulator of G protein signaling 17, transcript variant X1
regulator of G protein signaling 17, transcript variant X3
regulator of G-protein signaling 17 isoform X2
regulator of G-protein signaling 17 isoform X1
regulator of G-protein signaling 17 isoform X3
regulator of G protein signaling 17, transcript variant X4
regulator of G-protein signaling 17 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 mRNAs, 32 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interaction protein for cytohesin exchange factors 1, transcript variant X1
interaction protein for cytohesin exchange factors 1, transcript variant X5
interaction protein for cytohesin exchange factors 1, transcript variant X3
interaction protein for cytohesin exchange factors 1, transcript variant X2
interaction protein for cytohesin exchange factors 1, transcript variant X4
interactor protein for cytohesin exchange factors 1 isoform X1
interactor protein for cytohesin exchange factors 1 isoform X3
interactor protein for cytohesin exchange factors 1 isoform X2
interactor protein for cytohesin exchange factors 1 isoform X4
CNKSR family member 3, transcript variant X1
connector enhancer of kinase suppressor of ras 3 isoform X1
CNKSR family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
connector enhancer of kinase suppressor of ras 3 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
SR-related CTD associated factor 8, transcript variant X12
SR-related CTD associated factor 8, transcript variant X10
SR-related CTD associated factor 8, transcript variant X4
SR-related CTD associated factor 8, transcript variant X7
SR-related CTD associated factor 8, transcript variant X9
SR-related CTD associated factor 8, transcript variant X13
SR-related CTD associated factor 8, transcript variant X5
SR-related CTD associated factor 8, transcript variant X3
SR-related CTD associated factor 8, transcript variant X6
SR-related CTD associated factor 8, transcript variant X8
SR-related CTD associated factor 8, transcript variant X11
SR-related CTD associated factor 8, transcript variant X2
SR-related CTD associated factor 8, transcript variant X15
SR-related CTD associated factor 8, transcript variant X17
SR-related CTD associated factor 8, transcript variant X16
SR-related CTD associated factor 8, transcript variant X14
SR-related CTD associated factor 8, transcript variant X1
SR-related CTD associated factor 8, transcript variant X18
TIAM Rac1 associated GEF 2, transcript variant X3
TIAM Rac1 associated GEF 2, transcript variant X1
TIAM Rac1 associated GEF 2, transcript variant X7
TIAM Rac1 associated GEF 2, transcript variant X6
TIAM Rac1 associated GEF 2, transcript variant X2
TIAM Rac1 associated GEF 2, transcript variant X4
TIAM Rac1 associated GEF 2, transcript variant X5
rho guanine nucleotide exchange factor TIAM2 isoform X1
rho guanine nucleotide exchange factor TIAM2 isoform X3
rho guanine nucleotide exchange factor TIAM2 isoform X2
dimethyladenosine transferase 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
hydroxyacyl-coenzyme A dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
MAPK-interacting and spindle-stabilizing protein-like
AT-rich interactive domain-containing protein 1B
uncharacterized LOC122684156, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122684156, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 14, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 14, transcript variant X4
zinc finger DHHC-type palmitoyltransferase 14, transcript variant X5
zinc finger DHHC-type palmitoyltransferase 14, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine active site containing 1, transcript variant X5
serine active site containing 1, transcript variant X2
serine active site containing 1, transcript variant X4
serine active site containing 1, transcript variant X3
serine active site containing 1, transcript variant X1
general transcription factor IIH subunit 5, transcript variant X2
general transcription factor IIH subunit 5, transcript variant X1
general transcription factor IIH subunit 5, transcript variant X3
general transcription factor IIH subunit 5 isoform X2
general transcription factor IIH subunit 5 isoform X1
proline-rich protein HaeIII subfamily 1-like
TUB like protein 4, transcript variant X1
TUB like protein 4, transcript variant X2
hydroxyacyl-thioester dehydratase type 2, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transmembrane protein 181, transcript variant X1
transmembrane protein 181, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
dynein light chain Tctex-type 1, transcript variant X1
dynein light chain Tctex-type 1, transcript variant X2
dynein light chain Tctex-type 1 isoform X2
dynein light chain Tctex-type 1 isoform X1
synaptotagmin like 3, transcript variant X4
synaptotagmin like 3, transcript variant X3
synaptotagmin like 3, transcript variant X1
synaptotagmin like 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
synaptotagmin like 3, transcript variant X5
radial spoke head 3, transcript variant X2
radial spoke head 3, transcript variant X1
T cell activation RhoGTPase activating protein
T-cell activation Rho GTPase-activating protein
fibronectin type III domain containing 1
fibronectin type III domain-containing protein 1
uncharacterized LOC122684352, transcript variant X2
uncharacterized LOC122684352, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122684352, transcript variant X3
uncharacterized LOC122684352, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
superoxide dismutase [Mn], mitochondrial
uncharacterized LOC122684200, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC122684200, transcript variant X3
uncharacterized LOC122684200, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
WT1 associated protein, transcript variant X3
WT1 associated protein, transcript variant X2
WT1 associated protein, transcript variant X1
WT1 associated protein, transcript variant X4
pre-mRNA-splicing regulator WTAP isoform X1
pre-mRNA-splicing regulator WTAP isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00401
COORDINATES: nucleotide motif:Rfam:12.0:RF00429
39S ribosomal protein L18, mitochondrial
PARN like ribonuclease domain containing exonuclease 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
MAS1 proto-oncogene, G protein-coupled receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cation-independent mannose-6-phosphate receptor
solute carrier family 22 member 1, transcript variant X2
solute carrier family 22 member 1, transcript variant X1
solute carrier family 22 member 1 isoform X2
solute carrier family 22 member 1 isoform X1
mitochondrial import receptor subunit TOM20 homolog
solute carrier family 22 member 3, transcript variant X2
solute carrier family 22 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 22 member 3, transcript variant X1
solute carrier family 22 member 3 isoform X1
solute carrier family 22 member 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 ESTs, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
mitogen-activated protein kinase kinase kinase 4, transcript variant X1
mitogen-activated protein kinase kinase kinase 4, transcript variant X4
mitogen-activated protein kinase kinase kinase 4, transcript variant X5
mitogen-activated protein kinase kinase kinase 4, transcript variant X3
mitogen-activated protein kinase kinase kinase 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 4 isoform X1
mitogen-activated protein kinase kinase kinase 4 isoform X4
mitogen-activated protein kinase kinase kinase 4 isoform X5
mitogen-activated protein kinase kinase kinase 4 isoform X3
mitogen-activated protein kinase kinase kinase 4 isoform X6
mitogen-activated protein kinase kinase kinase 4, transcript variant X2
mitogen-activated protein kinase kinase kinase 4 isoform X2
mitogen-activated protein kinase kinase kinase 4, transcript variant X8
mitogen-activated protein kinase kinase kinase 4 isoform X8
mitogen-activated protein kinase kinase kinase 4, transcript variant X7
mitogen-activated protein kinase kinase kinase 4 isoform X7
1-acylglycerol-3-phosphate O-acyltransferase 4, transcript variant X2
1-acylglycerol-3-phosphate O-acyltransferase 4, transcript variant X5
1-acylglycerol-3-phosphate O-acyltransferase 4, transcript variant X4
1-acylglycerol-3-phosphate O-acyltransferase 4, transcript variant X1
1-acylglycerol-3-phosphate O-acyltransferase 4, transcript variant X3
1-acyl-sn-glycerol-3-phosphate acyltransferase delta isoform X2
1-acyl-sn-glycerol-3-phosphate acyltransferase delta isoform X1
1-acyl-sn-glycerol-3-phosphate acyltransferase delta isoform X3
1-acyl-sn-glycerol-3-phosphate acyltransferase delta isoform X4
parkin RBR E3 ubiquitin protein ligase, transcript variant X4
E3 ubiquitin-protein ligase parkin isoform X3
parkin RBR E3 ubiquitin protein ligase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
parkin RBR E3 ubiquitin protein ligase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
parkin RBR E3 ubiquitin protein ligase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
parkin RBR E3 ubiquitin protein ligase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
parkin RBR E3 ubiquitin protein ligase, transcript variant X5
parkin RBR E3 ubiquitin protein ligase, transcript variant X7
E3 ubiquitin-protein ligase parkin isoform X2
E3 ubiquitin-protein ligase parkin isoform X1
E3 ubiquitin-protein ligase parkin isoform X5
E3 ubiquitin-protein ligase parkin isoform X4
E3 ubiquitin-protein ligase parkin isoform X6
parkin coregulated, transcript variant X1
parkin coregulated, transcript variant X2
parkin coregulated gene protein isoform X1
parkin coregulated gene protein isoform X2
uncharacterized LOC122684416, transcript variant X1
uncharacterized LOC122684416, transcript variant X2
QKI, KH domain containing RNA binding, transcript variant X6
QKI, KH domain containing RNA binding, transcript variant X7
QKI, KH domain containing RNA binding, transcript variant X5
QKI, KH domain containing RNA binding, transcript variant X1
QKI, KH domain containing RNA binding, transcript variant X4
QKI, KH domain containing RNA binding, transcript variant X2
QKI, KH domain containing RNA binding, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
non-histone chromosomal protein HMG-14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
chromosome 26 C6orf118 homolog, transcript variant X1
chromosome 26 C6orf118 homolog, transcript variant X4
chromosome 26 C6orf118 homolog, transcript variant X2
chromosome 26 C6orf118 homolog, transcript variant X3
uncharacterized protein C6orf118 homolog isoform X4
uncharacterized protein C6orf118 homolog isoform X2
uncharacterized protein C6orf118 homolog isoform X1
uncharacterized protein C6orf118 homolog isoform X3
phosphodiesterase 10A, transcript variant X2
phosphodiesterase 10A, transcript variant X1
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform X2
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform X1
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ribosomal protein S6 kinase A2, transcript variant X2
ribosomal protein S6 kinase A2, transcript variant X1
ribosomal protein S6 kinase A2, transcript variant X4
ribosomal protein S6 kinase A2, transcript variant X5
ribosomal protein S6 kinase A2, transcript variant X3
ribosomal protein S6 kinase alpha-2 isoform X3
ribosomal protein S6 kinase alpha-2 isoform X2
ribosomal protein S6 kinase alpha-2 isoform X1
transfer RNA arginine (anticodon GCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
centrosomal protein 43, transcript variant X1
centrosomal protein 43, transcript variant X2
C-C motif chemokine receptor 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
C-C motif chemokine receptor 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C-C motif chemokine receptor 6, transcript variant X2
C-C motif chemokine receptor 6, transcript variant X4
C-C motif chemokine receptor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
C-C chemokine receptor type 6 isoform X1
C-C chemokine receptor type 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins
afadin, adherens junction formation factor, transcript variant X16
afadin, adherens junction formation factor, transcript variant X1
afadin, adherens junction formation factor, transcript variant X4
afadin, adherens junction formation factor, transcript variant X9
afadin, adherens junction formation factor, transcript variant X6
afadin, adherens junction formation factor, transcript variant X12
afadin, adherens junction formation factor, transcript variant X3
afadin, adherens junction formation factor, transcript variant X2
afadin, adherens junction formation factor, transcript variant X11
afadin, adherens junction formation factor, transcript variant X13
afadin, adherens junction formation factor, transcript variant X5
afadin, adherens junction formation factor, transcript variant X14
afadin, adherens junction formation factor, transcript variant X7
afadin, adherens junction formation factor, transcript variant X10
afadin, adherens junction formation factor, transcript variant X15
afadin, adherens junction formation factor, transcript variant X8
kinesin family member 25, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kinesin family member 25, transcript variant X2
FERM domain containing 1, transcript variant X2
FERM domain containing 1, transcript variant X3
FERM domain containing 1, transcript variant X4
FERM domain containing 1, transcript variant X5
FERM domain containing 1, transcript variant X1
FERM domain containing 1, transcript variant X6
FERM domain containing 1, transcript variant X7
FERM domain containing 1, transcript variant X10
FERM domain containing 1, transcript variant X9
FERM domain-containing protein 1 isoform X2
FERM domain-containing protein 1 isoform X3
FERM domain-containing protein 1 isoform X4
FERM domain-containing protein 1 isoform X1
FERM domain containing 1, transcript variant X13
FERM domain containing 1, transcript variant X11
FERM domain containing 1, transcript variant X8
FERM domain-containing protein 1 isoform X8
FERM domain-containing protein 1 isoform X6
FERM domain-containing protein 1 isoform X5
FERM domain containing 1, transcript variant X12
FERM domain-containing protein 1 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122684501, transcript variant X2
uncharacterized LOC122684501, transcript variant X1
26S proteasome non-ATPase regulatory subunit 8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 111 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dishevelled binding antagonist of beta catenin 2, transcript variant X1
dishevelled binding antagonist of beta catenin 2, transcript variant X2
SPARC related modular calcium binding 2, transcript variant X1
SPARC related modular calcium binding 2, transcript variant X2
SPARC-related modular calcium-binding protein 2 isoform X1
SPARC-related modular calcium-binding protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122684351, transcript variant X4
uncharacterized LOC122684351, transcript variant X3
uncharacterized LOC122684351, transcript variant X2
uncharacterized LOC122684351, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122684382, transcript variant X1
uncharacterized LOC122684382, transcript variant X2
uncharacterized LOC122684446, transcript variant X2
uncharacterized LOC122684446, transcript variant X1
uncharacterized LOC122684409, transcript variant X2
uncharacterized LOC122684409, transcript variant X1
WD repeat domain 27, transcript variant X3
WD repeat domain 27, transcript variant X2
WD repeat domain 27, transcript variant X4
WD repeat domain 27, transcript variant X1
WD repeat domain 27, transcript variant X5
WD repeat domain 27, transcript variant X6
WD repeat-containing protein 27 isoform X3
WD repeat-containing protein 27 isoform X2
WD repeat-containing protein 27 isoform X1
WD repeat-containing protein 27 isoform X4
WD repeat-containing protein 27 isoform X5
WD repeat-containing protein 27 isoform X6
PHD finger protein 10, transcript variant X2
PHD finger protein 10, transcript variant X1
dynein light chain Tctex-type 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dynein light chain Tctex-type protein 2 isoform X1
dynein light chain Tctex-type 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
dynein light chain Tctex-type protein 2 isoform X2
ER membrane associated RNA degradation, transcript variant X1
ER membrane associated RNA degradation, transcript variant X3
ER membrane associated RNA degradation, transcript variant X7
ER membrane associated RNA degradation, transcript variant X4
ER membrane associated RNA degradation, transcript variant X2
ER membrane associated RNA degradation, transcript variant X5
ER membrane associated RNA degradation, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
endoplasmic reticulum membrane-associated RNA degradation protein isoform X1
endoplasmic reticulum membrane-associated RNA degradation protein isoform X3
endoplasmic reticulum membrane-associated RNA degradation protein isoform X6
endoplasmic reticulum membrane-associated RNA degradation protein isoform X5
endoplasmic reticulum membrane-associated RNA degradation protein isoform X2
endoplasmic reticulum membrane-associated RNA degradation protein isoform X4
ER membrane associated RNA degradation, transcript variant X8
endoplasmic reticulum membrane-associated RNA degradation protein isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 120B, transcript variant X2
family with sequence similarity 120B, transcript variant X5
family with sequence similarity 120B, transcript variant X6
family with sequence similarity 120B, transcript variant X7
family with sequence similarity 120B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
family with sequence similarity 120B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
family with sequence similarity 120B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
constitutive coactivator of peroxisome proliferator-activated receptor gamma isoform X3
constitutive coactivator of peroxisome proliferator-activated receptor gamma isoform X4
constitutive coactivator of peroxisome proliferator-activated receptor gamma isoform X1
constitutive coactivator of peroxisome proliferator-activated receptor gamma isoform X2
TATA-box binding protein, transcript variant X1
TATA-box binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments